ArticleJHEP reports : innovation in hepatology2024

Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers.

Yuta Myojin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.